Platinum Asset Management has said it is opting to ‘sacrifice upside’ in order to avoid the worst of the losses ...
Despite the world rushing to find a vaccine for COVID-19, biotech and healthcare funds have not been able to maintain ...
A New Zealand healthcare firm is one of the few stocks to see a material increase in its share price ...
An Australian healthcare stock has outpaced its peers with returns approaching 700% during 2019 after it was admitted to the ...
Low-debt companies can help drive consistent returns for environmental, social and governance investors, according to research from Hejaz Financial Services.
While value investing has taken a beating in recent years, Peter Wilmshurst writes that there’s still opportunity to be found ...
The Federal Treasury has been told that the early release of superannuation should not be used to plug some of ...
Association of Superannuation Funds of Australia chief executive, Dr Martin Fahey has urged a continuing pluralist approach to the delivery ...
ETF Securities has launched the CURE exchange-traded fund, which will offer investors exposure to healthcare biotechnology companies.
In financial markets, excitement drives headlines. Equity markets rise, fall, and recover — creating stories that capture attention. Yet sustainable...
Winner of Executive of the Year – Funds Management 2025After years at Goldman Sachs and Credit Suisse, Jonathan Belz founded...
Cryptocurrency liquidity has become a cornerstone of sophisticated wealth management strategies, with real-time settlement capabilities revolutionizing traditional investment approaches. The...
In this episode of Relative Return, host Laura Dew chats with Roy Keenan, co-head of fixed income at Yarra Capital...
